Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vor Biopharma Inc.

25.54
+0.54002.16%
Volume:61.83K
Turnover:1.60M
Market Cap:175.05M
PE:-0.07
High:26.76
Open:25.22
Low:25.10
Close:25.00
52wk High:65.80
52wk Low:2.62
Shares:6.85M
Float Shares:3.18M
Volume Ratio:0.40
T/O Rate:1.95%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-342.6591
EPS(LYR):-34.0333
ROE:-125.43%
ROA:-121.29%
PB:-0.12
PE(LYR):-0.75

Loading ...

Vor Bio files to sell 51M shares of common stock for holders

TIPRANKS
·
Sep 25

Vor Biopharma Inc Files for Offering of up to 51.0 Mln Common Shares by the Selling Stockholders - SEC Filing

THOMSON REUTERS
·
Sep 25

BUZZ-Vor Biopharma climbs after Stifel upgrades rating on autoimmune drug potential

Reuters
·
Sep 24

Vor Biopharma Inc : Stifel Raises to Buy From Hold; Raises Target Price to $55 From $0.3 to Reflect Stock Split

THOMSON REUTERS
·
Sep 24

Vor Biopharma Inc. Appoints Navid Z. Khan, Ph.D., as Chief Medical Affairs Officer to Enhance Autoimmune Disease Treatment Strategy

Reuters
·
Sep 23

Vor Bio Appoints Navid Z. Khan, Ph.d., as Chief Medical Affairs Officer

THOMSON REUTERS
·
Sep 23

Vor Biopharma trading halted, news pending

TIPRANKS
·
Sep 19

Vor Bio Announces Oral Presentation of 48-Week China Phase 3 Generalized Myasthenia Gravis Clinical Study at Aanem

THOMSON REUTERS
·
Sep 18

Vor Biopharma Announces 1-for-20 Reverse Stock Split

TIPRANKS
·
Sep 17

Vor Biopharma Inc - Files for 1-for-20 Reverse Stock Split - SEC Filing

THOMSON REUTERS
·
Sep 17

Reprogrammed Interchange LLC Reports Disposal of Common Shares of Vor Biopharma Inc

Reuters
·
Sep 16

Vor Biopharma Inc. to Participate in Stifel Virtual Immunology and Inflammation Forum

Reuters
·
Sep 13

Reprogrammed Interchange LLC Reports Disposal of Common Shares of Vor Biopharma Inc

Reuters
·
Sep 11

Vor Biopharma Inc. Files Initial Statement of Beneficial Ownership for Director Sarah Burgess Reed

Reuters
·
Sep 09

Reprogrammed Interchange LLC Reports Disposal of Common Shares of Vor Biopharma Inc

Reuters
·
Sep 06

Vor Biopharma Inc. Appoints Adi Osovsky as General Counsel to Support Strategic Growth

Reuters
·
Sep 02

Vor Bio Appoints Adi Osovsky, S.j.d. as General Counsel

THOMSON REUTERS
·
Sep 02

Beneficial Owner Reprogrammed Interchange LLC Reports Disposal of Common Shares of Vor Biopharma Inc

Reuters
·
Aug 28

Vor Biopharma Inc. Announces Board Resignations and Appointment of Sarah Reed as New Director

Reuters
·
Aug 28

Vor Bio Says Telitacicept Achieves Primary Endpoint in Phase 3 Kidney Disease Study

MT Newswires Live
·
Aug 27